Stocks in News: Ascena Retail Group, AcelRx Pharmaceuticals, MGIC Investment, Santarus

Lakeway, NY -- (SBWIRE) -- 03/05/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Ascena Retail Group Inc (NASDAQ:ASNA) shares gained 10.41% to $18.25 in the morning hour after the company yesterday eported second quarter net income of $47.2 million or $0.29 per share, as compared to $63.7 million or $0.40 per share in the year-ago quarter. Income from continuing operations for the second quarter was $37.8 million or $0.23 per share, as compared to $63.7 million or $0.40 per share in the prior year quarter. Adjusted income from continuing operations for the latest second quarter was $42.9 million or $0.26 per share. Net sales for the quarter increased 44% to $1.24 billion from $862 million in the comparable quarter last year. Analysts expected the company to earn $0.23 per share on revenue of $1.23 billion for the second quarter.

Is ASNA a Strong After The recent price Movement? Let’s Find out Here

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) stock jumped 5.22% to $5.24 after the company yesterday announced top-line data results demonstrating that the first of two pivotal placebo-controlled Phase 3 studies for its investigational sublingual Sufentanil NanoTab PCA (patient-controlled analgesia) System met its primary endpoint. Adverse events reported in the study were generally mild or moderate in nature and similar in both placebo and treatment groups. The primary endpoint evaluated pain intensity over the 48-hour study period compared to baseline, or Summed Pain Intensity Difference (SPID-48), in patients following major open abdominal surgery.

Is ACRX a Strong Buying Opportunity After The Recent Slump? Find out Here

MGIC Investment Corp. (NYSE:MTG) shares climbed 16.75% to $4.88. The company, on Feb. 28, reported a net loss for the quarter ended December 31, 2012 of $386.7 million, compared with a net loss of $135.3 million for the same quarter a year ago. Diluted loss per share was $1.91 for the quarter ending December 31, 2012, as compared to diluted loss per share of $0.67 for the same quarter a year ago.

Is MTG Signaling a Buy Signal After The recent Volatility? Let’s Find out Here

Santarus, Inc. (NASDAQ:SNTS) stock increased 8.40% to $14.96 after the company yesterday announced that for fiscal 2013, it expects total revenues of approximately $320 million to $325 million, net income of approximately $50 million to $54 million, and diluted EPS of $0.63 to $0.68, adjusted EBITDA, or non-GAAP adjusted earnings, of approximately $73 million to $79 million and non-GAAP adjusted diluted EPS of $0.92 to $1.00. Analysts are expecting the Company to report revenue of $323 million, net income of $50 million, EBITDA of $60 million and EPS of $0.70 for fiscal 2013.

Is SNTS a Strong Buying Opportunity After The Recent Gain? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.